红花黄色素注射液对急性非ST段抬高型心肌梗死患者高敏C反应蛋白及血小板聚集率的影响  

Effect of Safflower Yellow Injection on High Sensitivity C-reactive Protein and Platelet Aggrega-tion Rate in Patients With non-ST Elevation Acute Myocardial Infarction

作　　者：胡宏俊[1] 祝伟宏[2] 欧玉平[2] 樊桂春 

机构地区：[1]湖南省资兴市第一人民医院心内科,湖南资兴423400 [2]湖南省郴州市第一人民医院,湖南郴州423000

出　　处：《医学临床研究》2014年第5期983-984,987,共3页Journal of Clinical Research

摘　　要：【目的】研究红花黄色素注射液对急性非 ST段抬高型心肌梗死（NSTEAMI）患者高敏 C反应蛋白（hsCRP）及血小板聚集率的影响。【方法】将71例 NSTEAMI患者随机分为红花黄色素注射液治疗组（n＝34）和常规治疗对照组（n＝37）。治疗组在对照组的基础上静脉点滴红花黄色素注射液，每次100 mg，每日1次，用药14 d。检测2组治疗前后 hsCRP及血小板聚集率。【结果】治疗组 hsCRP及血小板聚集率均较对照组显著降低（P＜0．05）。【结论】红花黄色素注射液可改善 NSTEAMI患者的预后，可以作为治疗心肌梗死的辅助药物。[Objective]To explore the effect of safflower yellow inj ection on high sensitivity C reactive protein（hsCRP）and platelet aggregation rate in patients with non-ST elevation acute myocardial infarction （NSTEAMI）.[Methods]Totally 7 1 NSTEAMI patients were randomly divided into safflower yellow inj ection treatment group and routine control group.On the basis of the treatment of control group,the treatment group was additionally given safflower yellow injection 100mg once a day for 14 days.The hsCRP and platelet aggregation rate in two groups before and after treatment.[Results]Compared with the control group,hsCRP and platelet aggregate rate in the treatment group decreased significantly（P〈0.05）.[Conclusion]Safflower yellow inj ection can improve the prognosis of patients with NSTEAMI,and can be used as the adj uvant thera-py of acute myocardial infarction.

关 键 词：心肌梗死 急性病 C反应蛋白质 血小板聚集 

分 类 号：R542.22[医药卫生—心血管疾病]